EA treatment reduced the expression of c-JUN and c-JUN terminal kinase (JNK) in the hippocampus of CUMS depression model rats, suggesting that EA alleviates depression by regulating the MAPK/JNK signaling pathway [160]. The gene discussed is JUN; the disease is depressive disorder.